308 related articles for article (PubMed ID: 19601801)
1. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
Reiss AB; Anwar K; Wirkowski P
Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
[TBL] [Abstract][Full Text] [Related]
2. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
3. LOX-1 receptor: A potential link in atherosclerosis and cancer.
Balzan S; Lubrano V
Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
[TBL] [Abstract][Full Text] [Related]
4. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
Dunn S; Vohra RS; Murphy JE; Homer-Vanniasinkam S; Walker JH; Ponnambalam S
Biochem J; 2008 Jan; 409(2):349-55. PubMed ID: 18092947
[TBL] [Abstract][Full Text] [Related]
5. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
Cimmino G; Cirillo P; Conte S; Pellegrino G; Barra G; Maresca L; Morello A; Calì G; Loffredo F; De Palma R; Arena G; Sawamura T; Ambrosio G; Golino P
Cardiovasc Res; 2020 May; 116(6):1125-1135. PubMed ID: 31504248
[TBL] [Abstract][Full Text] [Related]
7. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
Singh S; Gautam AS
Curr Atheroscler Rep; 2019 Jul; 21(10):38. PubMed ID: 31350594
[TBL] [Abstract][Full Text] [Related]
8. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
[TBL] [Abstract][Full Text] [Related]
9. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
Zeya B; Arjuman A; Chandra NC
Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
[TBL] [Abstract][Full Text] [Related]
10. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
[TBL] [Abstract][Full Text] [Related]
11. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
Ishiyama J; Taguchi R; Yamamoto A; Murakami K
Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
[TBL] [Abstract][Full Text] [Related]
12. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
Chen M; Masaki T; Sawamura T
Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
[TBL] [Abstract][Full Text] [Related]
13. "Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation.
Roper BWR; Tiede C; Abdul-Zani I; Cuthbert GA; Jade D; Al-Aufi A; Critchley WR; Saikia Q; Homer-Vanniasinkam S; Sawamura T; McPherson MJ; Harrison MA; Tomlinson DC; Ponnambalam S
J Biol Chem; 2023 Nov; 299(11):105325. PubMed ID: 37805141
[TBL] [Abstract][Full Text] [Related]
14. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.
Xu S; Liu Z; Huang Y; Le K; Tang F; Huang H; Ogura S; Little PJ; Shen X; Liu P
Transl Res; 2012 Aug; 160(2):114-24. PubMed ID: 22677363
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
17. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
Kumano-Kuramochi M; Shimozu Y; Wakita C; Ohnishi-Kameyama M; Shibata T; Matsunaga S; Takano-Ishikawa Y; Watanabe J; Goto M; Xie Q; Komba S; Uchida K; Machida S
Biochem J; 2012 Feb; 442(1):171-80. PubMed ID: 22077443
[TBL] [Abstract][Full Text] [Related]
18. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
Arjuman A; Chandra NC
Diab Vasc Dis Res; 2013 Sep; 10(5):442-51. PubMed ID: 23811604
[TBL] [Abstract][Full Text] [Related]
19. Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).
Ohki I; Amida H; Yamada R; Sugihara M; Ishigaki T; Tate S
Biochim Biophys Acta; 2011 Feb; 1814(2):345-54. PubMed ID: 21035571
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
Liu Z; Xu S; Huang X; Wang J; Gao S; Li H; Zhou C; Ye J; Chen S; Jin ZG; Liu P
Br J Pharmacol; 2015 Dec; 172(23):5661-75. PubMed ID: 25572313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
